Filter News
Area of Research
- (-) Biology and Environment (34)
- Advanced Manufacturing (7)
- Clean Energy (57)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Energy Frontier Research Centers (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (46)
- Fusion Energy (15)
- Isotope Development and Production (1)
- Isotopes (5)
- Materials (137)
- Materials Characterization (1)
- Materials for Computing (19)
- Materials Under Extremes (1)
- National Security (27)
- Neutron Science (49)
- Nuclear Science and Technology (38)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (95)
- Transportation Systems (1)
News Topics
- (-) Artificial Intelligence (9)
- (-) Coronavirus (13)
- (-) Frontier (3)
- (-) Fusion (1)
- (-) Materials Science (6)
- (-) Nanotechnology (7)
- (-) Nuclear Energy (1)
- (-) Physics (2)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Big Data (9)
- Bioenergy (45)
- Biology (73)
- Biomedical (16)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (40)
- Composites (5)
- Computer Science (19)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (89)
- Exascale Computing (4)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (8)
- Materials (12)
- Mathematics (3)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- National Security (3)
- Net Zero (2)
- Neutron Science (4)
- Partnerships (5)
- Polymers (2)
- Renewable Energy (1)
- Simulation (14)
- Summit (10)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory and the Georgia Institute of Technology is using supercomputing and revolutionary deep learning tools to predict the structures and roles of thousands of proteins with unknown functions.
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.